期刊文献+

苯基棕榈酰胺吗啡丙醇对卵巢癌多药耐药调节的实验研究 被引量:3

Modulation of multidrug resistance by 1-phenyl-2-palmitoylamino-3-morpholino-1-propanol in SKOV3-adriamycin-resistant cell line
原文传递
导出
摘要 目的 研究葡糖酰基鞘氨醇合酶抑制剂苯基棕榈酰胺吗啡丙醇 (PPMP)对耐阿霉素卵巢癌细胞亚株SKOV3 AdrR的多药耐药基因mdr1及P 糖蛋白的调节。方法 应用细胞培养技术对SKOV3 AdrR细胞进行PPMP处理 ,采用逆转录 聚合酶链反应技术分析mdr1mRNA的表达 ,流式细胞仪检测细胞内罗丹明的荧光强度。结果 浓度为 5、15 μmol L的PPMP可部分抑制SKOV3 AdrR细胞mdr1mRNA的表达 ,2 5 μmol L的PPMP可完全抑制SKOV3 AdrR细胞mdr1mRNA的表达 ,调节作用呈浓度依赖性。PPMP可增加SKOV3 AdrR细胞内罗丹明的荧光强度 ,随着PPMP浓度 (分别为 5、15、2 5μmol L)的增加 ,细胞内罗丹明的荧光强度逐渐增高 (分别为 3 0 1 2 2、3 89 98、4 2 6 0 8)。 结论 PPMP可逆转SKOV3 AdrR的多药耐药性。 Objective To study the modulation of mdr1 and P glycoprotein (P gp) by 1 phenyl 2 palmitoylamino 3 morpholino 1 propanol (PPMP) in SKOV3 adriamycin resistant (SKOV3/AdrR) cell line Methods SKOV3/AdrR cells were treated with PPMP, mRNA expression of multidrug resistant (mdr1) gene was analyzed by reverse transcriptase polymerase chain reaction Intracellular rhodamine (Rh123) concentration was measured by flow cytometry Results PPMP was found to inhibit mdr1 expression of SKOV3/AdrR at the mRNA level This modulation of gene expression was content dependent and complete inhibition appeared at 25 μmol/L PPMP treatment PPMP could increase intracellular Rh123 accumulation in SKOV3/AdrR cells After 15, 25 μmol/L PPMP treatment, Rh123 accumulation in SKOV3/AdrR was markedly enhanced Rh123 fluorescence intensity were 389 98,426 08 respectively ( P <0 05) Conclusions PPMP could modulate mdr1 expression at the mRNA level in a content dependent manner P gp mediated outward efflux of cytotoxic agents can be blocked by PPMP in SKOV3/AdrR cell PPMP possesses multi drug resistance activity in ovarian cancer
出处 《中华妇产科杂志》 CAS CSCD 北大核心 2001年第8期493-495,共3页 Chinese Journal of Obstetrics and Gynecology
基金 国家自然科学基金资助项目 ( 3970 0 14 3 39870 813)
关键词 吗啡类 鞘脂类 MDR基因 P-糖蛋白 逆转录聚合酶链反应 流式细胞术 卵巢癌 Morpholines Sphingolipids Genes,MDR P glycoprotein Reverse transcriptase polymerase chain reaction Flow cytometry
  • 相关文献

参考文献6

二级参考文献14

  • 1梁正东,卞度宏.卵巢癌细胞对顺铂耐药及其逆转的实验研究[J].中华妇产科杂志,1996,31(2):75-78. 被引量:21
  • 2周友珍,陈惠祯,杨庆忆,刘诗权,侯汉英.人卵巢癌顺铂耐药细胞株的建立及其耐药机制的研究[J].中华医学杂志,1996,76(9):680-683. 被引量:27
  • 3熊世钢 陈毓仙 等.两株人卵巢癌细胞系(COC1,COC2)的建立及特性[J].中华肿瘤杂志,1993,15(1):22-22.
  • 4郭祖超,医用数理统计方法,1987年
  • 5吕时铭,国外医学妇产科学分册,1990年,17卷,195页
  • 6郑国强,DNA、RNA分子杂交技术,1996年,25页
  • 7张霆钧,实用肿瘤杂志,1994年,9卷,102页
  • 8张霆钧,针刺研究,1994年,19卷,69页
  • 9李建勇,中华内科杂志,1997年,36卷,304页
  • 10Lavie Y,J Biol Chem,1997年,272卷,3期,1682页

共引文献25

同被引文献34

  • 1杨泉,张健,汪森明,张积仁.葡萄糖神经酰胺合酶基因在多药耐药肿瘤细胞株KBV_(200)的表达及其与肿瘤多药耐药性的关系[J].第一军医大学学报,2004,24(7):779-783. 被引量:4
  • 2[1]UCHIDA Y,ITOH M,TAGUCHI Y,et al.Ceramide reduction and transcriptional up-regulation of glucosylceramide synthase through doxorubicin-activated Sp1 in drug-resistant HL-60/ADR cells[J].Cancer Res,2004,64 (17):6271-6279.
  • 3[2]BLEICHER R J,CABOT M C.Glucosylceramide synthase and apoptosis[J].Biochim Biophys Acta,2002,1585 (223):172-178.
  • 4[3]NORMAN S R.Chemotherapy by slowing glucosphingolipid synthesis[J].Biochem Pharmacol,1999,57 (6):5892-5951.
  • 5[4]SIETSMA H,VELDMAN R J,KOK J W,et al.The involvement of sphingolipids in multidrug resistance[J].Membr Biol,2001,181 (3):153-162.
  • 6[5]LIU Y Y,HAN T Y,YU J Y,et al.Oligonucleotides blocking glucosylceramide synthase expression selectively reverse drug resistance in cancer cells[J].Lipid Res,2004,45(5):933-940.
  • 7[6]GOTTESMAN M M,FOJO T,BATES S E.Multidrug resistance in cancer:role of ATP-dependent transporters[J].Nat Rev Cancer,2002,2(1):48-58.
  • 8[7]GOUAZE V,YU J Y,BLEICHER R J,et al.Overexpression of glucosylceramide synthase and P-glycoprotein in cancer cells selected for resistance to natural product chemotherapy[J].Mol Cancer Ther,2004,3 (5):633-639.
  • 9[8]GOUAZE V,LIU Y Y,PRICKETT C S.Glucosylceramide synthase blockade down-regulates P-glycoprotein and resensitizes multidrug-resistant breast cancer cells to anticancer drugs cancer[J].Cancer Res,2005,65 (9):3861-3867.
  • 10[9]VELDMAN R J,KLAPPE K,HINRICHS J,et al.Altered sphingolipid metabolism in multidrug resistant ovarian cancer cells is due to uncoupling of glycolipid biosynthesis in the Golgi apparatus[J].FASEB J,2002,16(9):1111-1113.

引证文献3

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部